Medische Distikstofoxide Messer Belgium (Nitrous Oxide)

Nitrous oxide is inhaled and reaches the brain where it blocks NMDA receptors, modulates opioid pathways, and enhances GABAergic inhibition. These actions depress neuronal activity, producing analgesia, sedation, and at higher concentrations, loss of consciousness.

The dose of nitrous oxide is individualized and set by the prescribing clinician based on the patient’s age, weight, medical condition, and the specific procedure. Administration is titrated to achieve the desired level of analgesia or sedation while monitoring vital signs.

Safety data for nitrous oxide during pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant. Clinicians usually avoid routine use in pregnant or nursing patients unless absolutely necessary.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with volatile agents such as sevoflurane, nitrous oxide has a faster onset and recovery but provides less profound anesthesia. Unlike intravenous agents like propofol, it is administered by inhalation and does not require IV access. It is often used as an adjunct to reduce the concentration of other anesthetics.

Nitrous oxide cylinders should be stored at ambient temperature, in a well‑ventilated, dry area away from heat sources. Keep cylinders upright, secured to prevent tipping, and protect the valve from damage. Follow local regulations for compressed gas storage and handling.

Nitrous oxide is administered by inhalation through a calibrated delivery system, typically a face mask or nasal hood, mixed with oxygen. The concentration is adjusted by the clinician to achieve the desired analgesic or sedative effect while continuously monitoring the patient’s respiratory and cardiovascular status.

The most serious risks include hypoxia if oxygen supplementation is inadequate, severe hypotension, loss of consciousness, vitamin B12 deficiency with prolonged exposure, pulmonary edema, and the rare occurrence of malignant hyperthermia. Immediate medical attention is required if any of these events are suspected.

Nitrous oxide should be avoided in patients with untreated pneumothorax, severe chronic obstructive pulmonary disease, known hypersensitivity to the gas, or in situations where adequate oxygen delivery cannot be guaranteed. Caution is also advised for individuals with certain vitamin B12 deficiencies.